Primerica Reports Record 2025 Net Income & EPS, Boosts Dividend, and Authorizes New $475M Buyback
PRI is trading near its 52-week low of $230.09 (10% above the low) on light trading volume (0.4× avg).
Summary
Primerica reported record 2025 financial results with significant increases in net income, EPS, and revenue, driven by strong investment product sales. The company also announced a new $475 million share repurchase program and a higher quarterly dividend.
Key Events · Earnings and Guidance · PRI
-
Record Net Income and EPS Growth
Net income for 2025 increased by 60% to $751.2 million, and diluted EPS rose by 67% to $22.91, reflecting strong overall financial performance.
-
Robust Revenue and Investment Product Sales
Total revenues grew by 7% to $3.29 billion, with Investment and Savings Products sales increasing by 24% to $14.93 billion and client asset values growing by 15% to $128.89 billion.
-
Increased Shareholder Returns
The Board authorized a new $475 million share repurchase program through December 31, 2026, replacing the fully utilized $450 million program. The company also declared a quarterly dividend of $1.20 per share for Q1 2026, an increase from the $4.16 total paid in 2025.
-
Successful Exit from Senior Health Business
The company completed the disposal of its Senior Health business as of September 30, 2024, eliminating a prior-year loss from discontinued operations and allowing for greater focus on core segments.
Analysis · PRI · Finance
Primerica, Inc. has filed its annual 10-K report, confirming and detailing its strong financial performance for the fiscal year ended December 31, 2025. The company achieved a significant 60% increase in net income and a 67% rise in diluted earnings per share compared to the prior year. This robust growth was driven by a 7% increase in total revenues and a substantial 24% surge in Investment and Savings Products sales, alongside a 15% growth in client asset values. The company continues its commitment to shareholder returns by authorizing a new $475 million share repurchase program and increasing its quarterly dividend to $1.20 per share, following a 26% increase in total dividends paid in 2025. The successful disposal of the Senior Health business in 2024 also positions the company for a more focused future.
At the time of this filing, PRI was trading at $253.72 on NYSE in the Finance sector, with a market capitalization of approximately $8.1B. The 52-week trading range was $230.09 to $296.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.